NCT03775629View on ClinicalTrials.gov

"Drug-Drug Interaction Study of CG100650 in Healthy Volunteers"

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

April 4, 2019

Study Completion Date

April 10, 2019

Conditions
Healthy
Interventions
DRUG

Polmacoxib and Tramadol combination

Tramadol hydrochloride , Polmacoxib

DRUG

Polmacoxib

Polmacoxib

DRUG

Tramadol hydrochloride

Tramadol hydrochloride (HCl)

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

CrystalGenomics, Inc.

INDUSTRY